Video blog: HER2-targeted agents

DEBU TRIPATHY
PUBLISHED: 8:38 AM, SAT DECEMBER 10, 2011
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.



Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Special Feature
Share Your Art
Related Articles
Cancer: Advice for Dealing With the Financial Burden
Hear financial expert and registered nurse Mary Ann Cagle discuss the financial burden of cancer, often a result of expensive treatments, appointments, and diagnostic tests. Learn where to look for possible financial support.
$auto_registration$